Manulife (Manufacturers Life Insurance)
BBOT

Manulife (Manufacturers Life Insurance)’s BridgeBio Oncology BBOT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$319K Sell
35,692
-18,500
-34% -$199K ﹤0.01% 2317
2025
Q4 		$670K Buy
+54,192
New +$657K ﹤0.01% 2035

Other funds holding BBOT

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s BBOT Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its BridgeBio Oncology (BBOT) stake by 34% in Q1 2026, selling an estimated $199K and leaving 35,692 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #2317.

Manulife (Manufacturers Life Insurance) first reported a position in BBOT in Q4 2025 and has held it in 2 quarters since. The position peaked at $670K in Q4 2025. 67 funds tracked by Wall St. Rank hold BBOT as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 35,692 shares of BridgeBio Oncology worth $319K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 18,500 BridgeBio Oncology shares in Q1 2026, an estimated $199K.
  • BridgeBio Oncology made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2317 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in BridgeBio Oncology in Q4 2025 and has held it in 2 quarters since.
  • Manulife (Manufacturers Life Insurance)'s BridgeBio Oncology position peaked at $670K in Q4 2025.
  • 67 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.